Details for New Drug Application (NDA): 021246

✉ Email this page to a colleague

NDA 021246 describes TAMIFLU, which is a drug marketed by Roche and is included in two NDAs. It is available from one supplier. Additional details are available on the TAMIFLU profile page.

The generic ingredient in TAMIFLU is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.

Summary for 021246

Tradename:	TAMIFLU
Applicant:	Roche
Ingredient:	oseltamivir phosphate
Patents:	0

Pharmacology for NDA: 021246

Mechanism of Action	Neuraminidase Inhibitors

Medical Subject Heading (MeSH) Categories for 021246

Antiviral Agents
Enzyme Inhibitors

Suppliers and Packaging for NDA: 021246

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246	NDA	Genentech, Inc.	0004-0822	0004-0822-05	1 BOTTLE, GLASS in 1 CARTON (0004-0822-05) / 60 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	FOR SUSPENSION;ORAL			Strength	EQ 12MG BASE/ML
Approval Date:	Dec 14, 2000	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	FOR SUSPENSION;ORAL			Strength	EQ 6MG BASE/ML
Approval Date:	Mar 21, 2011	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021246

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-002	Mar 21, 2011	⤷ Start Trial	⤷ Start Trial
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-001	Dec 14, 2000	⤷ Start Trial	⤷ Start Trial
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-002	Mar 21, 2011	⤷ Start Trial	⤷ Start Trial
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-001	Dec 14, 2000	⤷ Start Trial	⤷ Start Trial
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-001	Dec 14, 2000	⤷ Start Trial	⤷ Start Trial
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-002	Mar 21, 2011	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.